| |
|
|
|
Urovant Sciences Ltd  
|
|
16.2 0.02 (0%) |
03-05 16:00 |
|
Open: |
16.18 |
Pre close: |
16.18 |
Target:
|
18.98
|
|
High: |
16.2 |
Low: |
16.18 |
Resistance:
|
16.25
18.98
|
|
Volume: |
149,961 |
Market Cap: |
530M |
Support:
|
16.16
16.11
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
16.19
 |
MACD |
MACD(12,26):
|
0.03  |
|
MA(20): |
16.19 |
Signal(12,26,9): |
0.04 |
|
MA(100): |
14.21 |
Stochastic Oscillator |
%K(14,3):
|
58.97 |
|
MA(250): |
11.26 |
%D(3): |
57.16 |
|
Average Volume(K) |
3-Month: |
13176
|
52-Week |
High:
|
16.25 |
|
10-Days: |
8234 |
Low: |
6.55 |
|
RSI |
RSI(14):
|
60.56 |
Change(%): |
43.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-5.150 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
31.72 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-106.9 |
Shares Float (M) |
6.70 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
78.03 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
18.73 |
|
Forward EPS |
-4.430 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
237 |
|
Book Value (p.s.) |
-3.580 |
EBITDA (p.s.) |
-4.667 |
P/E |
-3.15 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-4.53 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-118.56 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-57.38 |
P/CF |
-4.33 |
|
|
|
|
|
|
